COO
Price
$72.48
Change
+$1.30 (+1.83%)
Updated
Jun 6, 04:47 PM (EDT)
Capitalization
19.72B
82 days until earnings call
FEMY
Price
$0.80
Change
-$0.00 (-0.00%)
Updated
Jun 6, 04:19 PM (EDT)
Capitalization
33.56M
61 days until earnings call
Interact to see
Advertisement

COO vs FEMY

Header iconCOO vs FEMY Comparison
Open Charts COO vs FEMYBanner chart's image
Cooper Companies (The)
Price$72.48
Change+$1.30 (+1.83%)
Volume$10.79K
Capitalization19.72B
Femasys
Price$0.80
Change-$0.00 (-0.00%)
Volume$3.5K
Capitalization33.56M
COO vs FEMY Comparison Chart
Loading...
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FEMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COO vs. FEMY commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COO is a Hold and FEMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (COO: $71.18 vs. FEMY: $0.80)
Brand notoriety: COO and FEMY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: COO: 228% vs. FEMY: 106%
Market capitalization -- COO: $19.72B vs. FEMY: $33.56M
COO [@Medical Specialties] is valued at $19.72B. FEMY’s [@Medical Specialties] market capitalization is $33.56M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COO’s FA Score shows that 0 FA rating(s) are green whileFEMY’s FA Score has 0 green FA rating(s).

  • COO’s FA Score: 0 green, 5 red.
  • FEMY’s FA Score: 0 green, 5 red.
According to our system of comparison, both COO and FEMY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COO’s TA Score shows that 5 TA indicator(s) are bullish while FEMY’s TA Score has 4 bullish TA indicator(s).

  • COO’s TA Score: 5 bullish, 5 bearish.
  • FEMY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, COO is a better buy in the short-term than FEMY.

Price Growth

COO (@Medical Specialties) experienced а -10.98% price change this week, while FEMY (@Medical Specialties) price change was -21.58% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.08%. For the same industry, the average monthly price growth was +5.35%, and the average quarterly price growth was +1.80%.

Reported Earning Dates

COO is expected to report earnings on Aug 27, 2025.

FEMY is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical Specialties (+2.08% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COO($19.7B) has a higher market cap than FEMY($33.6M). COO has higher P/E ratio than FEMY: COO (68.09) vs FEMY (4.17). COO YTD gains are higher at: -22.572 vs. FEMY (-27.282). COO has higher annual earnings (EBITDA): 895M vs. FEMY (-11.83M). COO has more cash in the bank: 135M vs. FEMY (8.69M). FEMY has less debt than COO: FEMY (2.86M) vs COO (2.77B). COO has higher revenues than FEMY: COO (3.67B) vs FEMY (1.09M).
COOFEMYCOO / FEMY
Capitalization19.7B33.6M58,631%
EBITDA895M-11.83M-7,564%
Gain YTD-22.572-27.28283%
P/E Ratio68.094.171,634%
Revenue3.67B1.09M335,407%
Total Cash135M8.69M1,553%
Total Debt2.77B2.86M96,822%
FUNDAMENTALS RATINGS
COO: Fundamental Ratings
COO
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
82
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
90
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COOFEMY
RSI
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 25 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
57%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FEMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DLNG3.680.01
+0.27%
Dynagas LNG Parners LP
RGEN126.770.22
+0.17%
Repligen Corp
IRMD60.68-0.10
-0.16%
iRadimed Corp
LAUR22.26-0.28
-1.24%
Laureate Education
DUO0.19-0.02
-9.71%
Fangdd Network Group Ltd

FEMY and

Correlation & Price change

A.I.dvisor tells us that FEMY and BLFS have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FEMY and BLFS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FEMY
1D Price
Change %
FEMY100%
-0.01%
BLFS - FEMY
29%
Poorly correlated
-2.41%
COO - FEMY
27%
Poorly correlated
+5.58%
LUCD - FEMY
27%
Poorly correlated
N/A
OM - FEMY
26%
Poorly correlated
+3.99%
GH - FEMY
25%
Poorly correlated
+1.38%
More